Antibiotic combinations of gram-negative infections in patients with cancer.
D000667:Ampicillin / Q000627:therapeutic use; D001419:Bacteria; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D002228:Carbenicillin / Q000627:therapeutic use*; D002512:Cephalothin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004926:Escherichia coli; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D007970:Leukopenia / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D011113:Polymyxins / Q000627:therapeutic use; D011550:Pseudomonas aeruginosa; D018805:Sepsis / Q000188:drug therapy; D014946:Wound Infection / Q000188:drug therapy
D005839:Gentamicins; D011113:Polymyxins; D000667:Ampicillin; D002228:Carbenicillin; D002512:Cephalothin